Home » Binx Health’s STD Diagnostic Earns Additional FDA Clearance
Binx Health’s STD Diagnostic Earns Additional FDA Clearance
Binx Health’s binx io molecular point-of-care testing system has received FDA clearance for detecting chlamydia and gonorrhea in men.
The system delivers lab-quality results from urine samples in approximately half an hour.
Binx previously received agency clearance in August 2019 for detecting chlamydia and gonorrhea in women.
Upcoming Events
-
07May
-
14May
-
30May